Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of its.
European biotech AlgoTx, the developer of first-in-class treatment ATX01 for chemotherapy-induced peripheral neuropathy (CIPN), announced today the success of a €20M Series B fundraising led by Relyens